| Product Code: ETC9940230 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cardiovascular Diagnostics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cardiovascular Diagnostics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cardiovascular Diagnostics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume Share, By Point-of-Care Testing, 2021 & 2031F |
3.7 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Cardiovascular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the United Kingdom |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of cardiovascular conditions |
4.2.3 Technological advancements leading to the development of more accurate and efficient cardiovascular diagnostic tools |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of cardiovascular diagnostic devices |
4.3.2 High cost associated with cardiovascular diagnostic tests and procedures |
4.3.3 Limited reimbursement policies for cardiovascular diagnostic services in the UK healthcare system |
5 United Kingdom (UK) Cardiovascular Diagnostics Market Trends |
6 United Kingdom (UK) Cardiovascular Diagnostics Market, By Types |
6.1 United Kingdom (UK) Cardiovascular Diagnostics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Electrocardiogram (ECG) system, 2021- 2031F |
6.1.4 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Resting ECG Systems, 2021- 2031F |
6.1.5 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Cardiopulmonary Stress Testing Systems, 2021- 2031F |
6.1.6 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Holter Monitoring Devices, 2021- 2031F |
6.1.7 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Event Monitoring Devices, 2021- 2031F |
6.1.8 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Implantable Loop Recorder (ILR), 2021- 2031F |
6.2 United Kingdom (UK) Cardiovascular Diagnostics Market, By Point-of-Care Testing |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Analyzers, 2021- 2031F |
6.2.3 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Lipoprotein Test Kits, 2021- 2031F |
6.2.4 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Angiotensin Test Kits, 2021- 2031F |
6.2.5 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Fibrinogen Test Kits, 2021- 2031F |
6.2.6 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Serum Uric Acid Test Kits, 2021- 2031F |
6.2.7 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By High-Sensitivity CRP (hs-CRP) Kits, 2021- 2031F |
6.3 United Kingdom (UK) Cardiovascular Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Cardiac Catheterization Labs, 2021- 2031F |
6.3.6 United Kingdom (UK) Cardiovascular Diagnostics Market Revenues & Volume, By Diagnostic Imaging Centers, 2021- 2031F |
7 United Kingdom (UK) Cardiovascular Diagnostics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cardiovascular Diagnostics Market Export to Major Countries |
7.2 United Kingdom (UK) Cardiovascular Diagnostics Market Imports from Major Countries |
8 United Kingdom (UK) Cardiovascular Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of new cardiovascular diagnostic technologies in the UK |
8.2 Number of cardiovascular diagnostic tests conducted annually in the UK |
8.3 Rate of early diagnosis of cardiovascular diseases in the UK |
9 United Kingdom (UK) Cardiovascular Diagnostics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cardiovascular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Cardiovascular Diagnostics Market Opportunity Assessment, By Point-of-Care Testing, 2021 & 2031F |
9.3 United Kingdom (UK) Cardiovascular Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Cardiovascular Diagnostics Market - Competitive Landscape |
10.1 United Kingdom (UK) Cardiovascular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cardiovascular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here